These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1836340)

  • 1. Resistance to non-depolarizing neuromuscular blocking agents.
    Hunter JM
    Br J Anaesth; 1991 Nov; 67(5):511-4. PubMed ID: 1836340
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacodynamics of non-depolarizing neuromuscular blocking agents.
    Hull CJ
    Br J Anaesth; 1982 Feb; 54(2):169-82. PubMed ID: 6460515
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance to nondepolarizing neuromuscular blocking agents.
    Tschida SJ; Graupe KJ; Hoey LL; Vance-Bryan K
    Pharmacotherapy; 1996; 16(3):409-18. PubMed ID: 8726599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of the nondepolarizing neuromuscular relaxants applied to calculation of bolus and infusion dosage regimens.
    Shanks CA
    Anesthesiology; 1986 Jan; 64(1):72-86. PubMed ID: 2935053
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuromuscular blockade: offset anomalies. Are they simply potency-related receptor bonding effects?
    Midgley JM; Stenlake JB
    J Pharm Pharmacol; 1997 Apr; 49(4):416-20. PubMed ID: 9232540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged paralysis from non-depolarizing neuromuscular blocking agents: an evaluation of risk factors.
    Kappes J; Weber A
    S D Med; 2014 Sep; 67(9):375-6. PubMed ID: 25244817
    [No Abstract]   [Full Text] [Related]  

  • 7. Binding of tubocurarine, fazadinium, pancuronium and Org NC 45 to serum proteins in normal man and in patients with cirrhosis.
    Duvaldestin P; Henzel D
    Br J Anaesth; 1982 May; 54(5):513-6. PubMed ID: 6122460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiepileptic-induced resistance to neuromuscular blockers: mechanisms and clinical significance.
    Soriano SG; Martyn JA
    Clin Pharmacokinet; 2004; 43(2):71-81. PubMed ID: 14748617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analytical pharmacodynamic model for nondepolarizing neuromuscular blocking agents.
    d'Hollander A; Delcroix C
    J Pharmacokinet Biopharm; 1981 Feb; 9(1):27-40. PubMed ID: 6453216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-pharmacodynamic-pharmacokinetic relationships of steroidal neuromuscular blocking agents.
    Wierda JM; Proost JH
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():45-54. PubMed ID: 8557006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of non-depolarizing curare-like drugs].
    Duvaldestin P
    Ann Anesthesiol Fr; 1981; 22(2):169-71. PubMed ID: 6115604
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mivacurium. A non-depolarizing neuromuscular blocking agent with short-lasting effect].
    Ostergaard D; Mogensen JV
    Ugeskr Laeger; 1998 Mar; 160(14):2126-30. PubMed ID: 9604687
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in humans.
    Tassonyi E; Szabó G; Vereczkey L
    Arzneimittelforschung; 1981; 31(10):1754-6. PubMed ID: 6274362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of rocuronium bromide in hepatic cirrhosis.
    Hunter JM
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():39-41. PubMed ID: 8557004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An overview of the pharmacokinetics and pharmacodynamics of rocuronium bromide].
    Iwasaki H
    Masui; 2006 Jul; 55(7):826-33. PubMed ID: 16856542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The depolarizing and non-depolarizing neuromuscular blocking agents.
    Lamid S; Wang RI
    Wis Med J; 1974 Jan; 73(1):S15-6. PubMed ID: 4273039
    [No Abstract]   [Full Text] [Related]  

  • 17. Resistance to competitive neuromuscular blocking agents in burn patients: a review.
    Owen RT
    Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):203-7. PubMed ID: 4021651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of renal and hepatic function on pharmacodynamics and pharmacokinetics of non-depolarizing muscle relaxants.
    Booij LH
    Pharm Weekbl Sci; 1987 Apr; 9(2):56-60. PubMed ID: 2954027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Muscle relaxants].
    Ota Y
    Masui; 1996 Dec; 45 Suppl():S212-9. PubMed ID: 9044940
    [No Abstract]   [Full Text] [Related]  

  • 20. Update on muscle relaxants.
    Feldman S
    Br J Hosp Med; 1994 Aug 17-Sep 6; 52(4):142, 144-8. PubMed ID: 8000675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.